» Authors » Kristin Wiisanen

Kristin Wiisanen

Explore the profile of Kristin Wiisanen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 169
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Skaar T, Myers R, Fillingim R, Callaghan J, Cicali E, Eadon M, et al.
Clin Transl Sci . 2024 Aug; 17(8):e70005. PMID: 39177194
Chronic pain is a prevalent condition with enormous economic burden. Opioids such as tramadol, codeine, and hydrocodone are commonly used to treat chronic pain; these drugs are activated to more...
2.
Hines L, Wilke R, Myers R, Mathews C, Liu M, Baye J, et al.
Clin Transl Sci . 2024 Jun; 17(6):e13822. PMID: 38860639
Specific selective serotonin reuptake inhibitors (SSRIs) metabolism is strongly influenced by two pharmacogenes, CYP2D6 and CYP2C19. However, the effectiveness of prospectively using pharmacogenetic variants to select or dose SSRIs for...
3.
Desai N, Ravindra N, Hall B, Al Alshaykh H, Lemke L, Eken E, et al.
Front Pharmacol . 2024 May; 15:1377132. PMID: 38783934
The University of Florida Health Precision Medicine Program plays a crucial role in delivering pharmacogenomics (PGx) result notes to providers who request PGx testing. Despite this, there is currently a...
4.
Wu J, Wang M, Bates J, Shaddock R, Wiisanen K
Curr Pharm Teach Learn . 2024 Jan; 16(3):221-230. PMID: 38281827
Background: Clinical pharmacogenomics is an expanding area in healthcare that relies heavily on pharmacists for advocacy and implementation. To support pharmacists' significant roles in clinical pharmacogenomics, pharmacy schools and colleges...
5.
Lemke L, Cicali E, Williams R, Nguyen K, Cavallari L, Wiisanen K
Clin Pharmacol Ther . 2023 Sep; 114(6):1350-1357. PMID: 37716912
The objective of this study was to characterize clinician response following standardization of pharmacogenetic (PGx) clinical decision support alerts at University of Florida (UF) Health. A retrospective analysis of all...
6.
Norris M, Dalton R, Alam B, Eddy E, Nguyen K, Cavallari L, et al.
Front Genet . 2023 Sep; 14:1249003. PMID: 37680199
This manuscript reports on a pilot program focused on implementing pharmacogenetic testing within the framework of an employer-sponsored medical plan at University of Florida (UF) Health. The aim was to...
7.
Lemke L, Alam B, Williams R, Starostik P, Cavallari L, Cicali E, et al.
Front Pharmacol . 2023 Aug; 14:1179364. PMID: 37645439
Pharmacogenetics (PGx) has the potential to improve health outcomes but cost of testing is a barrier for equitable access. Reimbursement by insurance providers may lessen the financial burden for patients,...
8.
Cicali E, Elchynski A, Thomas C, Alam B, Dalton R, Davis R, et al.
Am J Health Syst Pharm . 2023 May; 80(15):994-1003. PMID: 37166240
Purpose: To describe the implementation of CYP2C19 testing into clinical practice at University of Florida (UF) Health Gainesville hospital to guide proton pump inhibitor (PPI) dosing and the lessons learned...
9.
Cicali E, Lemke L, Al Alshaykh H, Nguyen K, Cavallari L, Wiisanen K
J Am Coll Clin Pharm . 2023 Jan; 5(11):1161-1175. PMID: 36589694
The vast majority of patients possess one or more pharmacogenetic variants that can influence optimal medication use. When pharmacogenetic data are used to guide drug choice and dosing, evidence points...
10.
Cicali E, Wiisanen K
Pharmacogenomics . 2022 Sep; 23(14):749-752. PMID: 36102178
Tweetable abstract Clinical phenoconversion needs to be incorporated when interpreting and applying results in clinical care. This article describes how this can be performed either manually or by utilizing online...